AmCham Slovakia


INNOVATION CONFERENCE: Slovakia needs to implement more innovations in healthcare

A pandemic has increased the importance of healthcare and its institutions to accelerate and expand their innovative efforts for the benefit of the patient. Innovation is driving healthcare transformation in order to improve patient care, reduce costs and make the work environment more attractive to doctors and healthcare professionals.

These include innovative approaches to treatment and diagnosis, the development of telemedicine, the introduction of virtual reality into medical procedures, digitization and more efficient use and protection of health data.

Medtech and innovative research also has the potential to become an important pillar of the Slovak economy with the creation of new jobs, if innovations are created at home in Slovakia. Experts agreed at a conference entitled The Importance of Innovation in Slovak Healthcare, organized today by the American Chamber of Commerce of the Slovak Republic with the support of partners under the auspices of the Ministry of Investment, Regional Development and Informatization of the Slovak Republic and the European Commission Representation in Slovakia.

Funding from European sources such as the RRF Recovery and Resilience Plan, the EU Next Generation Next Generation Renewal Fund, as well as the EU budget for 2021-2027, offer unique opportunities for the modernization of the Slovak healthcare system.

The conference shared experiences from existing projects using innovative technologies and approaches in healthcare, such as telemedicine in the treatment of pediatric cardiac patients in Bratislava or the use of virtual reality in the treatment of psychiatric patients (cognity care). New approaches in diagnostics were also discussed, especially in oncological patients, where the diagnosis of tissue and blood samples from patients is a basic prerequisite for innovative treatment. Bioconvergence was also a big topic - the future setting of medicine, where the differences between biology, engineering, nanotechnology and IT are blurred.

The partners of the conference were Merck Sharp & Dohme, s.r.o., Roche Slovensko, s.r.o., Microsoft Slovakia s.r.o.,, Deutsche Telekom IT Solutions Slovakia, IBM Slovakia, spol. s.r.o., Johnson & Johnson, s.r.o., Medtronic Slovakia, s.r.o., Siemens Healthineers, Novartis Slovakia s.r.o.,, AIslovakIA and OnkoAliancia.





Jan Hargaš.jpg

Jasper Kunow.jpg